A multi-targeting natural product, aiphanol, inhibits tumor growth and metastasis

Cancer is one of the main causes of death in humans worldwide, the development of more effective Anticancer drugs that can inhibit the malignant progression of Cancer cells is of great significance. Aiphanol is a natural product identified from the seeds of Arecaceae and the rhizome of Smilax glabra Roxb. Our preliminary studies revealed that it had potential antiangiogenic and antilymphangiogenic activity by directly targeting VEGFR2/KDR/Flk-1/3 and COX2 in endothelial cells. However, the influence of aiphanol on Cancer cells per se remains largely undefined. In this study, the effects and related mechanisms of aiphanol on Cancer growth and metastasis were evaluated in vitro and in vivo. Acute toxicity assay and pharmacokinetic analysis were utilized to investigate the safety profile and metabolism characteristics of aiphanol. We revealed that aiphanol inhibited the proliferation of various types of Cancer cells and the growth of xenograft tumors in mice and zebrafish models. The possible mechanism was associated with the inactivation of multiple kinases, including FAK, Akt and ERK, and the upregulation of Bax and cleaved Caspase-3 to promote Cancer cell Apoptosis. Aiphanol significantly inhibited Cancer cell migration and invasion, which was related to the inhibition of epithelial-mesenchymal transition (EMT) and F-actin aggregation. Aiphanol effectively attenuated the metastasis of several types of Cancer cells in vivo. In addition, aiphanol exerted no significant toxicity and had fast metabolism. Collectively, we demonstrated the Anticancer effects of aiphanol and suggested that aiphanol has potential as a safe and effective therapeutic agent to treat Cancer.

Aiphanol; EMT; anticancer growth and metastasis; apoptosis; kinase.